IMGN151
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IMGN151, covering 2026-02-20 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies [Phase 2]